Ion Beam Applications SA (EBR:IBAB)

Market Cap	340.36M
Revenue (ttm)	498.16M
Net Income (ttm)	9.25M
Shares Out	29.44M
EPS (ttm)	0.31
PE Ratio	36.84
Forward PE	16.63
Dividend	0.24 (2.11%)
Ex-Dividend Date	Jun 19, 2024

Volume	43,269
Average Volume	44,133
Open	11.26
Previous Close	11.12
Day's Range	11.16 - 11.48
52-Week Range	9.40 - 15.14
Beta	0.96
RSI	59.74
Earnings Date	May 22, 2025

About Ion Beam Applications

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production o...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,287
• Stock Exchange: Euronext Brussels
• Ticker Symbol: IBAB